Hexylcaine
From Wikipedia, the free encyclopedia
 |
|
|
Hexylcaine
|
|
| Systematic (IUPAC) name | |
| 1-cyclohexylaminopropan-2-yl benzoate | |
| Identifiers | |
| CAS number | |
| ATC code | ? |
| PubChem | |
| DrugBank | |
| Chemical data | |
| Formula | C16H23NO2 |
| Mol. mass | 261.359 g/mol |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | ? |
| Half life | <10 minutes |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status | |
| Routes | ? |
Hexylcaine hydrochloride, also called cyclaine (Merck) or osmocaine, is a short-acting local anesthetic. It acts by inhibiting sodium channel conduction. Overdose can lead to headache, tinnitus, numbness and tingling around the mouth and tongue, convulsions, inability to breathe, and decreased heart function.
 |
This pharmacology-related article is a stub. You can help Wikipedia by expanding it. |
